Advanced Insights into Competitive Endogenous RNAs (ceRNAs) Regulated Pathogenic Mechanisms in Metastatic...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Triple-negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic targets and significant heterogeneity.
• Metastasis, driven by epithelial-mesenchymal transition and stemness, is a major cause of mortality in TNBC.
• Current treatments for metastatic TNBC (mTNBC) are insufficient, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

• To review the role of post-translational regulation, specifically microRNAs and competitive endogenous RNA (ceRNA) networks, in mTNBC metastasis.
• To explore potential therapeutic strategies targeting ceRNA networks in mTNBC.
• To identify knowledge gaps and future research directions in the field of mTNBC metastasis.

Main Methods:

• Literature review focusing on studies investigating microRNA and ceRNA regulatory networks in TNBC metastasis.
• Analysis of genetic and epigenetic mechanisms contributing to metastatic phenotypes in mTNBC.
• Synthesis of current knowledge on the clinical implications of ceRNA alterations in mTNBC.

Main Results:

• Alterations in microRNA and ceRNA networks are implicated in driving metastatic phenotypes in TNBC, including epithelial-mesenchymal transition, stemness, migration, and invasion.
• These regulatory networks represent a promising avenue for developing novel therapeutic interventions for mTNBC.
• Despite advances, significant knowledge gaps remain regarding the precise mechanisms and clinical translation of targeting ceRNA networks.

Conclusions:

• Dysregulation of microRNA and ceRNA networks plays a critical role in mTNBC progression and metastasis.
• Targeting these networks offers a potential therapeutic window for improving clinical outcomes in mTNBC patients.
• Further research is needed to fully elucidate these complex regulatory mechanisms and translate them into effective clinical applications.